Pharmacokinetic-hemodynamic studies of transdermal nitroglycerin in congestive heart failure
- 1 February 1987
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 9 (2) , 420-425
- https://doi.org/10.1016/s0735-1097(87)80398-4
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Dose requirements and hemodynamic effects of transdermal nitroglycerin compared with placebo in patients with congestive heart failure.Circulation, 1985
- The brief saga of transdermal nitroglycerin discs: Paradise lost?The American Journal of Cardiology, 1984
- Sustained beneficial hemodynamic responses to large doses of transdermal nitroglycerin in congestive heart failure and comparison with intravenous nitroglycerinThe American Journal of Cardiology, 1984
- Hemodynamic and Hormonal Response to Transdermal Nitroglycerin in Normal Subjects and in Patients With Congestive Heart FailureJournal of the American College of Cardiology, 1983
- Steady state pharmacokinetic haemodynamic studies of intravenous nitroglycerin in congestive cardiac failure.British Journal of Clinical Pharmacology, 1983
- Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure.Circulation, 1983
- Arterial-venous nitroglycerin gradient during intravenous infusion in man.Circulation, 1982
- Human pharmacological studies of a new transdermal system containing nitroglycerinEuropean Journal of Clinical Pharmacology, 1982
- Pharmacokinetic-hemodynamic studies of nitroglycerin ointment in congestive heart failureThe American Journal of Cardiology, 1980
- Pharmacokinetic-hemodynamic studies of intravenous nitroglycerin in congestive cardiac failure.Circulation, 1980